Precipio, Inc. Logo

Precipio, Inc.

Provides blood cancer diagnostic services & products to improve accuracy for physicians & labs.

PRPO | US

Overview

Corporate Details

ISIN(s):
US74112Q1022 (+1 more)
LEI:
Country:
United States of America
Address:
12325 EMMET ST, 68164 OMAHA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Precipio, Inc. is a healthcare biotechnology company focused on eradicating cancer misdiagnosis through advanced hematopathology diagnostics. The company operates a dual business model, offering both clinical diagnostic services and proprietary diagnostic products. Its Clinical Services division provides high-accuracy blood cancer testing directly to physicians. The Products Division develops and commercializes technologies for other laboratories, including the HemeScreen® and Bloodhound™ molecular diagnostic kits for detecting mutations in blood cancers like AML and CML, and the IV-Cell™ culture media. By translating insights from its own clinical laboratory into commercial products, Precipio aims to provide solutions that enhance diagnostic accuracy, improve laboratory efficiency, and ensure patients receive correct diagnoses from the start.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Precipio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Precipio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Precipio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Labomar Logo
A CDMO developing custom supplements, medical devices & cosmetics for third-party clients.
Italy
LBM
Laboratorio Farmaceutico Erfo Logo
Full-service contract manufacturer of private label supplements and medical devices.
Italy
ERFO
Laboratorio Reig Jofre S.A. Logo
A pharmaceutical company making essential health products accessible in over 70 countries.
Spain
RJF
Laboratorios Farmaceuticos Rovi S.A. Logo
Integrated pharma firm developing prescription drugs and offering contract manufacturing services.
Spain
ROVI
LakeShore Biopharma Co., Ltd. Logo
Develops vaccines and therapeutic biologics for infectious diseases and cancer.
United States of America
LSB
Lantern Pharma Inc. Logo
Leverages AI and machine learning to discover and develop targeted cancer therapies.
United States of America
LTRN
Lantheus Holdings, Inc. Logo
Develops radiopharmaceutical diagnostics and therapies to help clinicians fight disease.
United States of America
LNTH
LAVA Therapeutics NV Logo
Develops bispecific gamma delta T cell engagers for solid and hematologic cancers.
United States of America
LVTX
Lavipharm S.A. Logo
Develops & distributes Rx/OTC medicines, supplements & cosmetics for key therapeutic areas.
Greece
LAVI
Clinical-stage biopharma developing oral therapies for neuropsychiatric diseases like schizophrenia.
United States of America
LBRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.